Expert Interview
A look at the potential of the Galleri test, a multi-cancer early detection blood test in development by GRAIL and the results from the PATHFINDER study presented at ESMO.
Ticker(s): ILMNInstitution: Tenet Healthcare
- Clinical Pathologist, board-certified in anatomic pathology
- Regularly reads cancer biopsies to diagnose and characterize the cancerous tissue
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
